LEADER 01424nam  2200361z- 450 
001 9910689453703321
005 20161209095648.0
035   $a(CKB)5860000000017476
035   $a(BIP)008704964
035   $a(EXLCZ)995860000000017476
100   $a20220406c2001uuuu  -u-         -
101 0 $aeng
200 14$aThe administration's prescription drug proposal $ehearing before the Subcommittee on Health of the Committee on Ways and Means, House of Representatives, One Hundred Sixth Congress, second session, May 11, 2000
215   $a1 online resource (iii, 74 p.) $cill
311   $a0-16-059311-5 
517   $aEconomic impacts of the Kyoto Protocol 
517   $aAdministration's prescription drug proposal 
606   $aEnvironmental economics$zUnited States
606   $aGreenhouse gas mitigation$xEconomic aspects$zUnited States
606   $aClimatic changes$xEconomic aspects$zUnited States
610   $aMedical care
610   $aOlder people
610   $aMedicare
610   $aLaw
610   $aMedical
615  0$aEnvironmental economics
615  0$aGreenhouse gas mitigation$xEconomic aspects
615  0$aClimatic changes$xEconomic aspects
712 02$aUnited States, Congress House Committee on Ways and Means Subcommittee on Health Staff,$4oth
906   $aBOOK
912   $a9910689453703321
996   $aThe administration's prescription drug proposal$93139934
997   $aUNINA